Activation of pyruvate dehydrogenase by dichloroacetate has the potential to induce epigenetic remodeling in the heart.
暂无分享,去创建一个
M. Suematsu | K. Fukuda | A. Yamaguchi | Tsunehisa Yamamoto | T. Hishiki | T. Iso | Heping Zhou | Y. Katsumata | Xiaoxiang Yan | Tomohiro Matsuhashi | J. Endo | K. Shinmura | M. Sano | K. Shirakawa | R. Kaneda | T. Ono | Anzai Atsushi | Yoshinori Katsumata | T. Yamamoto | Tsunehisa Yamamoto
[1] E. Michelakis,et al. A Nuclear Pyruvate Dehydrogenase Complex Is Important for the Generation of Acetyl-CoA and Histone Acetylation , 2014, Cell.
[2] M. Suematsu,et al. Endogenous Prostaglandin D2 and Its Metabolites Protect the Heart Against Ischemia–Reperfusion Injury by Activating Nrf2 , 2014, Hypertension.
[3] Joseph A. Hill,et al. HDAC-dependent ventricular remodeling. , 2013, Trends in cardiovascular medicine.
[4] Eric Verdin,et al. Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor , 2013, Science.
[5] M. Suematsu,et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. , 2013, Cell stem cell.
[6] Chao Lu,et al. Metabolic regulation of epigenetics. , 2012, Cell Metabolism.
[7] R. Deberardinis,et al. Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.
[8] S. Franklin,et al. Quantitative Analysis of the Chromatin Proteome in Disease Reveals Remodeling Principles and Identifies High Mobility Group Protein B2 as a Regulator of Hypertrophic Growth* , 2012, Molecular & Cellular Proteomics.
[9] E. Nagata,et al. Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway , 2012, Proceedings of the National Academy of Sciences.
[10] Richard T. Lee,et al. Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury. , 2012, The Journal of clinical investigation.
[11] T. Kerppola,et al. Opposing Roles of FoxP1 and Nfat3 in Transcriptional Control of Cardiomyocyte Hypertrophy , 2011, Molecular and Cellular Biology.
[12] Keiichi Fukuda,et al. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. , 2011, Cell metabolism.
[13] B. Spiegelman,et al. C/EBPβ Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling , 2010, Cell.
[14] Saptarsi M. Haldar,et al. Krüppel-like factor 4 regulates pressure-induced cardiac hypertrophy. , 2010, Journal of molecular and cellular cardiology.
[15] T. Soga,et al. Analysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart Failure , 2010, Circulation. Heart failure.
[16] H. Kee,et al. Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. , 2009, Journal of molecular and cellular cardiology.
[17] Alexander M. Wolf,et al. Metabolic Remodeling Induced by Mitochondrial Aldehyde Stress Stimulates Tolerance to Oxidative Stress in the Heart , 2009, Circulation research.
[18] G. Muscat,et al. β-Adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues , 2009, Molecular and Cellular Endocrinology.
[19] E. Michelakis,et al. A redox-metabolic-electrical remodeling in the diseased left and right ventricle: direct clinical implications in heart disease and beyond. Focus on "Role of gamma-glutamyl transpeptidase in redox regulation of K+ channel remodeling in postmyocardial infarction rat hearts". , 2009, American journal of physiology. Cell physiology.
[20] M. Zimmerman,et al. Role of gamma-glutamyl transpeptidase in redox regulation of K+ channel remodeling in postmyocardial infarction rat hearts. , 2009, American journal of physiology. Cell physiology.
[21] M. Murata,et al. Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. , 2009, The Journal of clinical investigation.
[22] C. Newgard,et al. A Glucose-to-Gene Link , 2009, Science.
[23] Justin R. Cross,et al. ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation , 2009, Science.
[24] I. Haber,et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle , 2009, Journal of Molecular Medicine.
[25] Sally J. Singh,et al. Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[26] Saptarsi M. Haldar,et al. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy , 2007, Proceedings of the National Academy of Sciences.
[27] J. Carazo,et al. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists , 2007, Genome Biology.
[28] N. Grishin,et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. , 2006, Molecular cell.
[29] E. Olson,et al. Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy , 2006, Circulation.
[30] M. Jeong,et al. Inhibition of Histone Deacetylation Blocks Cardiac Hypertrophy Induced by Angiotensin II Infusion and Aortic Banding , 2005, Circulation.
[31] Jiandie D. Lin,et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. , 2005, Cell metabolism.
[32] E. Olson,et al. Dose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors* , 2003, Journal of Biological Chemistry.
[33] K. M. Popov,et al. Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts. , 2002, Cardiovascular research.
[34] G. Lopaschuk,et al. Dichloroacetate improves postischemic function of hypertrophied rat hearts. , 2000, Journal of the American College of Cardiology.
[35] P. Stacpoole,et al. Effects of dichloroacetate in patients with congestive heart failure , 1998, Clinical cardiology.
[36] R. Bersin,et al. Dichloroacetate as metabolic therapy for myocardial ischemia and failure. , 1997, American heart journal.
[37] C. Van Lint,et al. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. , 1996, Gene expression.
[38] J. Ross,et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[39] K. Chien,et al. Erratum: Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy (Proc. Natl. Acad. Sci. USA (September 1991) 88 (8277-8281)) , 1991 .
[40] J. Hill,et al. Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. , 1988, The American journal of cardiology.
[41] D. Morris,et al. Metabolic fate of extracted glucose in normal human myocardium. , 1985, The Journal of clinical investigation.